Sorafenib/SBRT Yields OS Benefit in Locally Advanced Hepatocellular Carcinoma

被引：0
|
作者：
Seymour, Caroline
机构：
来源：
ONCOLOGY-NEW YORK | 2023年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [41] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Masayoshi Yada
    Akihide Masumoto
    Kenta Motomura
    Hirotaka Tajiri
    Yusuke Morita
    Hideo Suzuki
    Takeshi Senju
    Toshimasa Koyanagi
    World Journal of Gastroenterology, 2014, (35) : 12581 - 12587
  • [42] NICE guidance on sorafenib for treating advanced hepatocellular carcinoma
    Adler, Amanda I.
    Sutcliffe, Frances
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (11): : 781 - 782
  • [43] Hepatocellular carcinoma in advanced stage - improve survival with Sorafenib
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (06): : A2 - A4
  • [44] POTENTIAL BIOMARKERS OF SORAFENIB THERAPY IN ADVANCED HEPATOCELLULAR CARCINOMA
    Negri, Francesca V.
    Dal Bello, Barbara
    Campanini, Nicoletta
    Rossi, Sandro
    Porta, Camillo
    Tinelli, Carmine
    Poggi, Guido
    Missale, Gabriele
    Bisagni, Giancarlo
    Ardizzoni, Andrea
    Silini, Enrico M.
    ANNALS OF ONCOLOGY, 2011, 22 : v20 - v20
  • [45] Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma
    Zheng, Tianying
    Jiang, Hanyu
    Wei, Yi
    Huang, Zixing
    Chen, Jie
    Duan, Ting
    Song, Bin
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (03) : 382 - 394
  • [46] Sorafenib in unresectable hepatocellular carcinoma and advanced liver cirrhosis
    Pinter, M.
    Sieghart, W.
    Graziadei, I.
    Vogel, W.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S13 - S13
  • [47] Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma
    Kim, Jeong Eun
    Ryoo, Baek-Yeol
    Ryu, Min-Hee
    Chang, Heung-Moon
    Suh, Dong Jin
    Lee, Han Chu
    Lim, Young-Suk
    Kim, Kang Mo
    Kang, Yoon-Koo
    ONCOLOGY, 2012, 82 (02) : 119 - 125
  • [48] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Yada, Masayoshi
    Masumoto, Akihide
    Motomura, Kenta
    Tajiri, Hirotaka
    Morita, Yusuke
    Suzuki, Hideo
    Senju, Takeshi
    Koyanagi, Toshimasa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) : 12581 - 12587
  • [49] Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    ONCOLOGY LETTERS, 2014, 8 (05) : 2263 - 2266
  • [50] Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
    Huang, Song-Fong
    Chong, Sio-Wai
    Huang, Chun-Wei
    Hsu, Heng-Yuan
    Pan, Kuang-Tse
    Hung, Chien-Fu
    Wu, Tsung-Han
    Lee, Chao-Wei
    Hsieh, Chia-Hsun
    Wang, Ching-Ting
    Chai, Pei-Mei
    Yu, Ming-Chin
    BIOMEDICINES, 2022, 10 (09)
12345